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Abstract
Introduction and hypothesis The objective of this study
was the assessment of the efficiency of the MiniArc for
curing stress urinary incontinence.
Methods Seventy-seven patients, operated on from March
2008 to November 2009, were evaluated in this study. One-
year post-operative data are presented. All patients suffered
from predominant stress urinary incontinence. After 1 year,
response was 74%. Evaluation was performed using a
questionnaire consisting of the EuroQol-5 Dimensions, the
Patient Global Impression of Improvement, the Inconti-
nence Impact Questionnaire, the Urinary Distress Inventory,
the Prolapse/Urinary Incontinence Sexual Questionnaire,
short form, and the Defecation Distress Inventory.
Results One year after surgery, 68% of the patients stated
an improvement in their incontinence status, while only
44% stated to be completely dry.
Conclusion The 1-year follow-up suggests that the Mini-
Arc is less effective in the treatment of stress urinary
incontinence than the TVT.
Keywords Quality of life.Questionnaires.Stress urinary
incontinence.Suburethral sling
Introduction
It is estimated that urinary incontinence (UI) affects 10–
40% of the female population aged 15–64 years and has an
even higher incidence after 65 years of age [1–3]. UI is
defined as the uncontrolled and involuntary leakage of
urine [4] and is associated with a reduction in quality of life
(QoL) for women of all ages [1–3]. To assess this
reduction, QoL questionnaires are commonly used and
focus on the consequences of urinary incontinence [5–9].
Stress urinary incontinence (SUI) is described as urinary
incontinence following increase of abdominal pressure as in
sneezing or coughing and is due to a weakening of the
muscles and connective tissue of the pelvic floor.
The wide acceptance of surgery with mid-urethral slings
(MUS) as intervention for SUI is due to the effectiveness,
rapidity, and minimal invasiveness of the techniques so far.
After the first-generation (the tension-free vaginal tape,
TVT) and second-generation (the trans-obturator tape, TOT,
and the tension-free vaginal tape–obturator, TVT-O) tapes,
the industry developed third-generation vaginal tapes, the
MiniArc (introduced in 2007 by American Medical
Systems) and TVT-Secur (introduced in 2006 by Women's
Health & Urology, Ethicon, Johnson & Johnson). The TVT,
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DOI 10.1007/s00192-011-1605-yTVT-O, and the TOT all show cure rates ranging from 84%
to 100% after a minimum follow-up of 1 year [10].
The MiniArc uses self-fixating tips and is performed
with a single incision in the anterior vaginal wall. With this
design, the procedure aims to accomplish minimal tissue
damage by lowering the number of incisions from three to
one. Also, needle penetration of the obturator foramen or
the retropubic space is avoided, thereby minimizing tissue
and (potential) organ damage.
Studies of the MiniArc [11–18] show a variance in
success rate (range, 69.1–91.4%), after a minimum follow-
up of 1 year. Although these studies all assess cure rate of
the MiniArc, only the articles of De Ridder et al. and
Pickens et al. [11, 18] discuss the impact on everyday
functioning and QoL.
It is important to mention that no restrictions were made
regarding the study population on the base of severity of SUI,
age, BMI, etc. The aim of this study is to perform a 1-year
post-operative evaluation of the treatment of SUI using the
MiniArc sling with a focus on the efficacy, quality of life, and
daily functioning.
Material and methods
A prospective study was performed at the Department of
Gynecology of the Flevo Hospital, Almere. In this hospital,
77 primary interventions with the MiniArc were performed
by one gynecologist (IMC) from March 2008 to November
2009.
The patient population consisted of women aged 29–
82 years who all had clinically established predominant
SUI. If a patient was suspected of having urge incontinence
due to detrusor overactivity, full urodynamics were per-
formed. In the case of identified detrusor instability, the
patient was subsequently excluded from the study. Patients
were asked to complete questionnaires pre-operatively and
1 year post-operatively.
Inclusion criteria were predominant SUI and a minimum
follow-up of 1 year post-surgery. Exclusion criteria were
predominant urge incontinence and previous surgery for SUI.
It is important to mention that the tape was positioned
against the urethra without compression, but the overall
placement of the MiniArc was tighter than the traditional
MUS. This study was approved by the medical ethics
review board of the Flevo Hospital, Almere.
Outcome
Failure of the procedure was defined as persistent SUI,
stated by the patient in the questionnaire as loss of urine
upon exertion, coughing, or sneezing. Patients not reporting
any amount of leakage were considered cured. A post-
voidal residual volume of 150 ml was considered as the
maximum acceptable and treated with Ubretid (5 mg/day)
and/or (self) catheterization.
Questionnaire
The questionnaire used has been validated by the Dutch
Association for Obstetrics and Gynecology in cooperation
with the Dutch Association of Urology to evaluate the
impact of urinary incontinence. The questionnaire consists
of 47 multiple choice questions and is divided in five
sections that evaluate physical condition (health status),
micturition status, defecation status, coping of the patient
(emotional status), and sexual functioning.
The first part consists of the 5-Dimensional EuroQol
instrument (EQ-5D) [19]. The EQ-5D is specifically
designed to evaluate five different subcategories of the
patient's current physical condition (mobility, self-care, daily
activities, pain/complaints, mood) and is scored from 1 (no
complaints) to 3 (serious complaints). The first part also
includes a Visual Analog Scale (VAS), as well as a QOL
scale to evaluate the overall health status of the patients.
The next parts evaluate the micturition status using the
Urogenital Distress Inventory (UDI) [7], the coping behavior
of the patients using the Incontinence Impact Questionnaire
(IIQ) [7], and the defecation status using the Defecation
Distress Inventory (DDI) [20]. The final part assesses sexual
functioning with sections of the Pelvic Organ Prolapse/
Urinary Incontinence Sexual Questionnaire-SF (PIS-Q short
form, limited to five questions [21]). The IIQ and UDI were
scored using the different domains as described by v/d Vaart
et al. [9].
The post-operative questionnaire was identical to the pre-
operative questionnaire except for the first question which
assessed the improvement/deterioration post-surgery with the
Patient Global Impression of Improvement (PGI-I) [22].
Statistical analysis
Results of both pre- and post-operative questionnaires were
scored, and for the UDI, IIQ, and DDI, outcomes were
converted in a scale ranging from 0 to 100 (higher=
negative). Statistics were performed in SPSS release 17
(SPSS Inc., Chicago, IL, USA). P values <0.05 were
considered statistically significant. For multiple compari-
sons, a Bonferroni correction was conducted after the
paired sample T test.
Results
All patients screened for SUI and eligible for surgery with
the MiniArc were asked to participate in our study and
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patients, 77 filled in the pre-operative questionnaire and
were thus eligible to be included in this study. Clinical
characteristics of this patient group are described in
Table 1.
After 1 year, these 77 patients were sent a copy of the
post-operative questionnaire of which 57 were returned
(74%). No differences were found in baseline character-
istics between responders and non-responders. Of the 77
patients who had primary surgery with the MiniArc, 10
(13%) were anesthetized locally and 67 (87%) had general
anesthesia.
Complications were seen in 6 of 77 patients (8%) and
resulted in one cleaving of the MiniArc due to deteriorating
urge incontinence. Other complications were dehiscence of
the wound (one patient) and a large residue (two patients,
300–600 ml; two patients, 150–300 ml). At the 6 week
check, all patients had normal emptying of their bladder.
Further investigation showed that the dehiscence was due to
a post-surgery hematoma and did not cause any problems
after the first week. Success and complications over time
are visualized in Table 2.
One-year post-surgery, 44% of the patients stated to be
completely continent (Table 3). The patient's subjective
satisfaction was scored ranging from “very much better” to
“very much worse,” using the PGI-I. After 1 year, 68% of
the patients rated their current situation as either being
“very much better” or “much better.” The other 32% stated
little improvement or even deterioration of their SUI in
comparison to their pre-operative status (Table 3).
Pre-operatively, overall QoL mean score was 4.6 with a
standard deviation of 0.9. One year after surgery, the QoL
did not differ from pre-surgery. The VAS did also not differ
significant 1 year after surgery.
The EQ-5D score did not show significant difference
with pre-operational status. The part of the questionnaire
concerning the micturition status was scored using the UDI
(five subcategories). After 1 year, all five subcategories
showed an improvement (Table 4).
The final part of the questionnaire discussed the distress
caused by the incontinence and the impact on everyday
functioning using the IIQ (five subcategories). Three out of
the five items were significantly improved after 1 year,
indicating a decrease in distress caused by SUI. The DDI
showed as expected no differences pre- and post-surgery.
The sexuality part (PIS-Q SF, not shown in a table) did not
show any relevant differences pre- and post-operatively.
No differences were found in baseline characteristics
between the “success” and “failure” patients (Table 5).
However, it was found that a BMI of 35 or higher was
negatively related to the success rate of the MiniArc
(Table 6).
Discussion
This prospective single-center study was designed to
evaluate the efficacy, safety and impact on quality of life
of the MiniArc procedure in women with SUI. Of the 57
evaluated patients, after 1 year, 32 (56%) stated again or
still experiencing SUI, thus indicating failure of the
Table 1 Clinical characteristics of patients treated with the MiniArc,
n=77
Age 52.1±12.6 (range, 29–80)
BMI 28.2±6.1 (range, 17, 63–50, 43)
Parity 2.3±0.9 (range, 1–6)
None 4 (5%)
1–3 68 (88%)
4, >4 5 (7%)
Education 3.4±1.7
Values are given as mean ± SD or percentage. Education rated from 1
(primary school) to 7 (university degree)
BMI Body mass index in kilograms per square meter
Table 2 Success and complication rate through time, n=77
Complications Success
rate
a
Response
b
First quartile 2 41.2% (7/17) 17/19=89%
Second quartile 2 50.0% (6/12) 12/19=63%
Third quartile 2 42.9% (6/14) 14/19=74%
Fourth quartile 0 42.9% (6/14) 14/20=70%
Total 6 Mean, 44.0 %
(25/57)
Total, 57
patients
Patients divided in quartiles (77/4=19 patients per quartile, 20 in the
fourth), chronological order
aPatient not experiencing any amount of leakage 1 year after surgery
bResponse after 1 year
Table 3 PGI-I, 1 year post-surgery
Very much better 16 (D=13, 3=ND) (28%)
Much better 23 (D=11, ND=12) (40%)
A little better 10 (D=1, ND=9) (17.5.5%)
No difference 6 (D=0, ND=6) (10.5.5%)
A little worse 0
Much worse 1 (D=0, ND=1) (2%)
Very much worse 1 (D=0, ND=1) (2%)
Total 57
Dry (success) 25 (44%)
Not dry (failure) 32 (56%)
Values are given as mean ± SD
D dry, ND not dry
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in 68% of the patients (Table 3).
Following surgery, an improvement was seen in everyday
functioning, as well as a significant drop in incontinence-
related distress. The DDI part of the questionnaire did not
show any significant improvements but was not specifically
associated with SUI. For the significant change in the
subcategory “genital prolapse” of the UDI, no explanation
could be found, but the improvement could be accredited to a
decrease of complaints in general.
Complications were seen in 6 of 77 patients (8%). The
rate of complications and success did not show any
significant improvement in time (Table 2). There are certain
limitations of this study that need to be addressed.
At present there is an ongoing discussion about the
amount of compression with which the mini-slings should
be positioned against the urethra. Up to now, no consensus
seems to be reached about a standardized method to place
these mini-slings as effective as possible. Because all the
surgeries in this study were performed by one gynecologist
Table 4 Comparison of pre- and post-operational scores of patients treated with the MiniArc, p<0.05=significant
Pre-operational, n=77 1-year, n=57 p value
b
QoL scale [1–6] 4.6±0.9 4.9±1.0 ns
EQ-5D 0.82±0.19 0.86±0.19 ns
VAS 73.8±17.2 77.3±13.3 ns
Incontinence-related distress (UDI)
Discomfort/pain 26.6±23.9 13.2±20.1 0.009
a
Urinary incontinence 58.9±24.1 23.4±25.0 0.000
a
Overactive bladder 30.7±24.6 13.7±18.7 0.000
a
Obstructive micturition 26.2±24.8 17.0±23.3 0.024
a
Genital prolapse 8.4±15.9 3.8±10.0 0.000
a
Impact on everyday functioning (IIQ)
Mobility 50.7±18.9 40.0±18.4 0.003
a
Emotional 49.9±18.3 37.1±14.7 0.000
a
Physical 40.2±16.1 32.6±12.6 ns
Social 34.3±13.2 29.6±10.7 ns
Embarrassment 53.0±21.6 41.0±17.9 0.006
a
Defecation disorders (DDI)
Constipation 11.2±19.8 9.4±15.8 ns
Painful defecation 9.3±18.0 7.3±15.8 ns
Fecal incontinence 7.1±16.8 7.6±16.4 ns
Flatus incontinence 18.6±25.7 23.4±26.0 ns
Values are given as mean ± SD. The p values were Bonferroni corrected. Scale from 1 (no complaints) to 100 (a lot of complaints). p value, pre-
operative compared to 1-year post-operative (n=57)
QoL Quality of life from 1 (very bad) to 6 (excellent), VAS Visual Analog Scale (1–100), EQ-5D EuroQol-5 Dimensions, ns not significant
aStatistically significant
bPaired-samples T test, UDI, IIQ, and DDI
Table 5 Clinical characteristics
of failures versus success 1 year
after MiniArc (n=57), p<0.05=
significant
Values are given as mean ± SD
or percentage. Education rated
from 1 (primary school) to 7
(university degree)
BMI Body mass index in
kilograms/square meter
aIndependent-samples T test
Success (dry) (n=25) Failure (not dry)
(n=32)
p value
a
Age 52.0±12.0 (range, 36–79) 56.0±13.5 (range, 29–80) 0.248
BMI 27.2±4.1 (range, 19.5–33.5) 29.70±7.6 (range, 17.9–50.4) 0.122
Parity 2.0±0.8 2.3±1.0 0.200
None 1 (4%) 1 (3%)
1–3 23 (92%) 29 (91%)
>4 1 (4%) 2 (6%)
Education 3.7±1.7 3.3±1.7 0.309
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However, the gynecologist that performed the surgery is an
experienced specialist in MUS surgery, as well as an AMS-
trained instructor for the placement of the MiniArc.
Nevertheless, we recommend this study to be repeated in
a multicenter setting using comparative patient groups.
The second limitation is the subjective definition of
failure in this study. This subjective measurement, however,
does provide information about the experience of the
patient over a longer period of time. So, despite the fact
that clinical tests after 1 year (Cough Stress Test (CST), pad
test, urodynamic investigation) would have guaranteed
objectivity, these investigations would merely reflect a
measurement at one point in time. We therefore feel that our
definition of cure (and failure) is valid to use.
Thirdly, it is possible that a misinterpretation of the
questions regarding the different types of incontinence
could have resulted in inaccurate results. At least part of the
patients indicating persistent SUI after 1 year could be in
fact experiencing (de novo) urge incontinence. Although
we feel that the question in the UDI regarding SUI is clear,
clinical tests will be needed to further validate the results
and exclude a possible bias.
The major advantage of this study is that multiple
questionnaires were used to assess the different improve-
ment or deterioration aspects post-surgery. According to the
International Continence Society and the International
Consultation on Incontinence, the UDI and the IIQ are
recommended as grade A-condition specific questionnaires
to be used in research [23].
Furthermore the PGI-I and the PIS-Q are recommended by
the International Urogynecological Association as validated
SUI outcome measures [24]. The extensiveness and many
different aspects of the questionnaires should make this study
valid to offer urologists and gynecologists reliable information.
Due to the fact that prior to the first included patient, our
gynecologist had only performed five MiniArc interventions,
a learning curve was expected. However, upon analyzing the
success and failure rates, no improvement in cure and
complication rate was found (Table 2). The absence of a
learning curve should lead to more reliable and valid results.
For our comparison with other studies, a literature
research was conducted in PubMed® using the terms
“SUI” and “MiniArc.” The found studies for the MiniArc
showed success rates ranging from 69% to 91% (11, 12,
14–17) and are visualized in Table 7. Our 1-year analysis
Table 6 Sub-categorical success and improvement rates 1-year post-surgery
Success (dry) Success (dry) p value
a
Complete population 44% (n=57) vs. BMI≥35 kg/m² (n=7) 0% 0.000
b
Complete population 44% (n=57) vs. Age≥65 years (n=15) 33% 0.347
Complete population 44% (n=57) vs. Parity≥3( n=14) 40% 0.181
Improved Improved p value
b
Complete population 86% (n=57) vs. BMI≥35 kg/m² (n=7) 57% 0.023
a
Complete population 86% (n=57) vs. Age≥65 years (n=15) 73% 0.200
Complete population 86% (n=57) vs. Parity≥3( n=14) 86% 0.368
Values are given as percentages
BMI Body mass index, Improved as stated in questionnaire (independent of success)
aIndependent-samples T test
bStatistically significant
Table 7 Other MiniArc studies ranked by number of patients
Study Number of patients Success rate (percentage) Definition of success Follow-up
Kennelly, MJ, et al. [15] 188 90.6 Negative CST 1 year
Jiménez Calvo J, et al. [14] 135 91.9 Negative CST 495 days (mean)
Pickens RB et al. [18] 120 93.5
a Subjective: no leakage 1 year
Hogewoning, CRC, et al.
a 77 44
a Subjective: no leakage 1 year
De Ridder, D, et al. [11] 75 85 Negative CST 1 year
Debodinance, P, et al. [12] 72 69.1 Negative CST 1 year
Moore, RD, et al. [16] 61 91.4 Negative CST 1 year
Sottner, O et al. [17]
a 38 76.7
a Subjective: no leakage 19 months
aNo objective outcome measures
Int Urogynecol J (2012) 23:589–595 593showed different results with a success rate as low as 44%.
It is clear that the success rate of our study is exceptionally
low, but two other studies (Sottner et al. [17]a n d
Debodinance et al. [12]) also present low rates of success.
Variances between subjective and objectives outcomes
are common in literature, but results are conflicting [25–
29]. No statement can be made whether subjective success
rates deviate from objective ones in either a negative or
positive way. Future research should include both objective
and subjective measurements that can then be either
analyzed separately or combined.
Characteristics of the patient population could also partly
explain the disappointing success rate. In this study, no
restrictions were made based on the severity of SUI and
BMI whereas certain others leave out patients with a
BMI >35 kg/m
2. The differences between the “success”
and “failure” population are visualized in Table 5 and do
not show any significant differences in clinical character-
istics. If the population is further subdivided in specific
categories (Table 6) ,i ti ss h o w nt h a taB M Io f3 5k g / m ²o r
more is an indication for a lower success rate, but higher
age (≥65) or a higher number of parities (≥3) is not related
to lower rates of success. Improvement rates in Table 6
also show that a BMI ≥35 kg/m² is a significant negative
factor in this research population.
The 20 patients (26%) that were lost to follow-up could
play a significant part in the accuracy of the evaluation as
well, although their characteristics did not show any
differences from the participating group.
Conclusion
The 1-year follow-up of the anti-incontinence treatment
using the MiniArc single incision sling revealed a high rate
of failure (56%), while showing improvement in 68%.
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